Elisha M. Wachman, MD
Associate Professor
Boston University School of Medicine
Dept of Pediatrics
Neonatology

MD, Boston University School of Medicine




Dr. Wachman received her MD from the BU School of Medicine before pursuing her pediatric residency at Boston Medical Center (BMC) and Children’s Hospital Boston. She then completed her neonatology fellowship at the Floating Hospital for Children at Tufts Medical Center. She is currently an attending neonatologist at BMC and a leader in neonatal opioid withdrawal syndrome (NOWS) quality improvement and research. Her research interests include the genetics and epigenetics of NOWS, treatments for maternal opioid use disorder (OUD), and the use of non-pharmacologic care methods to improve NOWS outcomes. She is currently the principal investigator of a NIH funded study examining the safety, efficacy, pharmacokinetics, pharmacogenomics, and long-term maternal and infant outcomes of naltrexone for pregnant women with OUD, and participates in several other NIH and foundation funded studies involving pregnant women with OUD / infants with NOWS. Dr. Wachman also researches perinatal COVID-19 transmission, including examination of placental and neonatal markers and long-term infant outcomes.

2018 America's Essential Hospitals Gage Award



The National Drug Abuse Treatment Clinical Trials Network (CTN-0080
06/01/2019 - 02/28/2024 (PI)
McLean Hospital NIH-NIDA

Safety, pharmacokinetics and efficacy of extended-release naltrexone in pregnant women with…
09/17/2018 - 05/31/2023 (PI)
NIH-NICHD
1R01HD096798-01

The National Drug Abuse Clinical Trials Network: New England
06/01/2020 - 02/28/2022 (PI)
Yale University School of Medicine National Institute o

MATernaL and Infant NetworK to Understand Outcomes Associated with Treatment for Opioid…
03/01/2020 - 07/31/2020 (PI)
Task Force for Global Health

Neonatal Abstinence Syndrome (NAS) Research and Quality Improvement Program
12/14/2016 - 08/31/2018 (PI)
Massachusetts Health Policy Commission


Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Devlin LA, Young LW, Kraft WK, Wachman EM, Czynski A, Merhar SL, Winhusen T, Jones HE, Poindexter BB, Wakschlag LS, Salisbury AL, Matthews AG, Davis JM. Neonatal opioid withdrawal syndrome: a review of the science and a look toward the use of buprenorphine for affected infants. J Perinatol. 2021 Sep 23. PMID: 34556799; PMCID: PMC8459143; DOI: 10.1038/s41372-021-01206-3;
     
  2. Borrelli KN, Yao EJ, Yen WW, Phadke RA, Ruan QT, Chen MM, Kelliher JC, Langan CR, Scotellaro JL, Babbs RK, Beierle JC, Logan RW, Johnson WE, Wachman EM, Cruz-Martín A, Bryant CD. Sex Differences in Behavioral and Brainstem Transcriptomic Neuroadaptations following Neonatal Opioid Exposure in Outbred Mice. eNeuro. 2021 Sep-Oct; 8(5).View Related Profiles. PMID: 34479978
     
  3. Epstein RL, Moloney C, Garfinkel J, Saia K, Wachman EM, Lodi S, Pelton SI. Enhancing Linkage to Hepatitis C Virus Treatment Following Pregnancy in Women Identified During Perinatal Care. Hepatol Commun. 2021 Sep; 5(9):1543-1554.View Related Profiles. PMID: 34510828; PMCID: PMC8435278; DOI: 10.1002/hep4.1748;
     
  4. Harris M, Joseph K, Hoeppner B, Wachman EM, Gray JR, Saia K, Wakeman S, Bair-Merritt MH, Schiff DM. A Retrospective Cohort Study Examining the Utility of Perinatal Urine Toxicology Testing to Guide Breastfeeding Initiation. J Addict Med. 2021 Jul-Aug 01; 15(4):311-317.View Related Profiles. PMID: 33060464; PMCID: PMC8044259; DOI: 10.1097/ADM.0000000000000761;
     
  5. Meyers S, Wachman EM. A Case of False-positive Amphetamine Results on Urine Toxicology Testing Secondary to Imatinib. J Addict Med. 2021 Jul-Aug 01; 15(4):349-351. PMID: 33181576
     
  6. Schiff DM, Partridge S, Gummadi NH, Gray JR, Stulac S, Costello E, Wachman EM, Jones HE, Greenfield SF, Taveras EM, Bernstein JA. Caring for Families Impacted by Opioid Use: A Qualitative Analysis of Integrated Program Designs. Acad Pediatr. 2021 Apr 24.View Related Profiles. PMID: 33901729
     
  7. Sabharwal V, Bartolome R, Hassan SA, Levesque BM, Camelo IY, Wachman EM, Figueira M, Yarrington CD, Cooper ER, Barnett ED, Parker MG. Mother-Infant Dyads with COVID-19 at an Urban, Safety-Net Hospital: Clinical Manifestations and Birth Outcomes. Am J Perinatol. 2021 06; 38(7):741-746.View Related Profiles. PMID: 33853145
     
  8. Gummadi NH, D'Amico M, Chandra P, Krumholz JO, Mumber HE, Hoyo L, Miller M, Borba CP, Wachman EM. Impact of cuddler service-learning program in medical student education of opioid use disorder in pregnancy and neonatal opioid withdrawal syndrome. Subst Abus. 2021 Apr 02; 1-6.View Related Profiles. PMID: 33797332
     
  9. Singh R, Houghton M, Melvin P, Wachman EM, Diop H, Iverson R, Picarillo A, Rhein L, Gupta M. Predictors of pharmacologic therapy for neonatal opioid withdrawal syndrome: a retrospective analysis of a statewide database. J Perinatol. 2021 06; 41(6):1381-1388. PMID: 33608626
     
  10. Benarroch Y, Juttukonda L, Sabharwal V, Boateng J, Khan AR, Yarrington C, Wachman EM, Taglauer E. Differential Expression of Rab5 and Rab7 Small GTPase Proteins in Placental Tissues From Pregnancies Affected by Maternal Coronavirus Disease 2019. Clin Ther. 2021 02; 43(2):308-318.View Related Profiles. PMID: 33541739; PMCID: PMC7837084; DOI: 10.1016/j.clinthera.2021.01.002;
     
Showing 10 of 53 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 53 publications over 11 distinct years, with a maximum of 10 publications in 2021

YearPublications
20102
20111
20131
20142
20153
20164
20174
20189
20198
20209
202110


Mandatory Reporting Law Is Harmful for Pregnant People with Substance Use Disorder

HealthCity 6/29/2021

Pregnant people infected with SARS-CoV-2 appear to be at higher risk of developing severe cases of COVID-19 than infected people who are not pregnant.

Technology.org 1/5/2021

Human Fetuses Can Contract SARS-CoV-2, but It’s Rare

The Scientist 1/1/2021

Researchers Identify Proteins That Prevent COVID-19 Transmission Through the Placenta

HealthCity 9/15/2020

Implementing Eat, Sleep, Console Model Improves Neonatal Opioid Withdrawal Syndrome Outcomes

HealthCity 9/2/2020

Pilot Study: Treating Opioid Use Disorder with Naltrexone During Pregnancy Shows Promise

MultiBrief Exclusive 9/19/2019

Using Naltrexone During Pregnancy Can Benefit Infants, Moms

The Fix 8/21/2019

BMC: Naltrexone Promising Treatment for Opioid Use Disorder During Pregnancy

Essential Hospitals 8/14/2019

Naltrexone May Offer Advantages Over Buprenorphine to Treat Opioid Use Disorder During Pregnancy

HealthCity 8/13/2019

Promotion to Associate Professor for 18 Medical Campus Faculty

BU Today 6/14/2019

‘Hugs Not Drugs’ for Opioid-Dependent Newborns

MedPage Today 4/30/2019

To The Moon And Back, SENSE Host Newborne Substance Abuse Event

Wicked Local Carve 4/23/2019

Buprenorphine Optimal Treatment For Neonatal Abstinence Syndrome

Healio 2/2/2019

Buprenorphine May Best Morphine for Treating NAS

MedPage Today 1/22/2019

‘I Know I Can Do It’: New Hampshire Moms In Recovery Learn New Methods Of Supporting Babies

The Boston Globe 10/15/2018

Amid opioid crisis, treatment for dependent infants evolves

The Columbian 8/27/2018

Babies Born Dependent On Opioids Need Touch, Not Tech

WBUR 8/16/2018
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Neonatal Opioid Withdrawal Syndrome
Contact for Mentoring:

771 Albany St
Boston MA 02118
Google Map


Wachman's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department